In vitro biochemical studies provide critical molecular insights into potential disease-causing mechanisms of MAPT mutations identified in humans affected by specific tauopathies including effects on tau aggregation, phosphorylation, and microtubule-binding (Ghetti et al., 2015; Strang et al., 2019). The gene discussed is MAPT; the disease is tauopathy.